Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis

BACKGROUND: Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system and is one of the leading causes of disability in young adults. Cell therapy is emerging as a therapeutic strategy to promote repair and regeneration in patients with disability associated w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EBioMedicine
Main Authors: Harris, Violaine K., Stark, James, Vyshkina, Tamara, Blackshear, Leslie, Joo, Gloria, Stefanova, Valentina, Sara, Gabriel, Sadiq, Saud A.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5925446/
https://ncbi.nlm.nih.gov/pubmed/29449193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.02.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados